Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.
-
Curative ends a major Salesforce (NYSE:CRM) contract and rolls out its own in-house, AI-powered CRM platform for healthcare operations.
-
The company cites cost and speed advantages from its internal system compared with Salesforce’s tools.
-
Salesforce responds by highlighting ongoing security and compliance challenges for AI driven platforms in regulated sectors such as healthcare.
-
The move raises fresh questions for investors about how generative AI could affect traditional SaaS models and client retention in sensitive industries.
Consider reviewing other companies building the infrastructure behind large scale AI tools through 56 AI infrastructure stocks.
Salesforce provides customer relationship management software that connects companies with their customers across the US, Europe, and the Asia Pacific. It often pitches its platform to large enterprises that need tools compatible with strict industry rules, such as those in healthcare.
We’ve flagged 1 risk for Salesforce. See which could impact your investment.
How Curative’s exit tests the Salesforce AI-agent Narrative
This Curative decision cuts straight to the core Salesforce narrative that AI-driven automation and data-centric workflows raise switching costs rather than erode them. The question for investors is whether this loss signals a broader risk from in-house builds or highlights why governed, compliant platforms still matter.
“The extension of SaaSonization, and conversational interfaces increases customer stickiness, protects against commoditization, and raises switching costs
The headline risk here is obvious. A healthcare operator has walked away from Salesforce in favor of its own AI-powered stack, which challenges the idea that higher automation always strengthens vendor lock-in. It also echoes the narrative’s warning that low-code and AI tools can commoditize traditional CRM, especially where cost and speed dominate the buying decision.
The counterpoint is that Salesforce is leaning hard into governed AI agents in regulated settings, as seen with its IL5 deployments and government wins, while warning about security and compliance gaps in homegrown systems. That aligns with the thesis that the real moat is controlled data access, audit trails and workflow governance, not just generic AI features that Microsoft or ServiceNow can also offer.
